Garcia-Bermudez, Javier
Badgley, Michael A.
Prasad, Sheela
Baudrier, Lou
Liu, Yuyang
La, Konnor
Soula, Mariluz
Williams, Robert T.
Yamaguchi, Norihiro
Hwang, Rosa F.
Taylor, Laura J.
de Stanchina, Elisa
Rostandy, Bety
Alwaseem, Hanan http://orcid.org/0000-0002-4946-1436
Molina, Henrik
Bar-Sagi, Dafna
Birsoy, Kıvanç http://orcid.org/0000-0002-7579-9895
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1K99CA248838-01)
Article History
Received: 1 February 2021
Accepted: 10 May 2022
First Online: 20 June 2022
Competing interests
: K.B. is scientific adviser to Nanocare Pharmaceuticals and a consultant to Barer Institute. The remaining authors declare no competing interests.